Magnolia extract put to the test against psoriasis inflammation
NCT ID NCT07471048
First seen Mar 29, 2026 · Last updated May 18, 2026 · Updated 9 times
Summary
This study tests whether a daily magnolia supplement called Viv can reduce immune-related proteins in the blood of adults with psoriasis. One hundred participants will take either Viv or a placebo for three months and provide blood samples at home. Researchers will measure changes in inflammatory markers to see if the supplement has a calming effect on the immune system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Decentralized Study Coordinating Center
RECRUITINGEnglewood, New Jersey, 07631, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.